Modification of methodology results in improvement in simultaneous kidney-islet success. [electronic resource]
Producer: 19950405Description: 1349-50 p. digitalISSN:- 0041-1345
- Antilymphocyte Serum -- therapeutic use
- Azathioprine -- therapeutic use
- C-Peptide -- blood
- Cells, Cultured
- Cyclosporine -- therapeutic use
- Diabetes Mellitus, Type 1 -- therapy
- Diabetic Nephropathies -- surgery
- Humans
- Immunosuppression Therapy -- methods
- Islets of Langerhans
- Islets of Langerhans Transplantation -- immunology
- Kidney Failure, Chronic -- surgery
- Kidney Transplantation -- immunology
- Muromonab-CD3 -- therapeutic use
- Postoperative Complications
- Prednisone -- therapeutic use
- Tissue Preservation
- Transplantation, Heterotopic
- Transplantation, Homologous
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.